- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04019132
Power During Functional Tasks in Older Adults
Power During Functional Tasks in Older Adults: Reliability, Reference Values and Relationship With Other Outcome Measurements Related to Sarcopenia
Study Overview
Detailed Description
Aging is associated with slower movement patterns, a higher fall risk and a restriction in functionality. This will lead to an increase in the number of dependent elderly and a high socio-economic burden. From the age of 40, a systematic loss of muscle mass and muscle force, also known as sarcopenia, will occur. In addition, performing daily tasks requires the production of muscle force at a certain speed. The product of force and speed, power, decreases even earlier and faster than muscle force.
This power is typically measured with specialized equipment, which limits the large-scale applicability. With the help of accelerometry there is the possibility to measure power during more functional tasks and movements, which benefits the applicability, but the reliability, reference values and link with other outcome measurements related to sarcopenia has to be investigated.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgium, 3000
- KU Leuven - Department of Movement Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age >20
Exclusion Criteria:
- Unstable cardiovascular diseases
- Fever or acute infection
- Cognitive or physical malfunctioning that hinders the understanding or performance of tests and/or instructions
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Older adults
Older adults aged >65 years
|
Body measurements, power and strength tests of the knee extensor muscle, handgrip strength, functional capacity tests, objective measurement of physical activity (subgroup of older adults, n=50)
|
|
Young group
Younger adults between the age of 20 and 40 years
|
Body measurements, power and strength tests of the knee extensor muscle, handgrip strength, functional capacity tests, objective measurement of physical activity (subgroup of older adults, n=50)
|
|
Middle-aged group 1
Adults between the age of 40 and 55 years
|
Body measurements, power and strength tests of the knee extensor muscle, handgrip strength, functional capacity tests, objective measurement of physical activity (subgroup of older adults, n=50)
|
|
Middle-aged group 2
Adults between the age of 55 and 65 years
|
Body measurements, power and strength tests of the knee extensor muscle, handgrip strength, functional capacity tests, objective measurement of physical activity (subgroup of older adults, n=50)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lower limb muscle power during a stair climb test
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
The power (watt) needed to perform stair climbing is calculated using a 3D accelerometer (DynaPort MoveTest, McRoberts), worn at the back of the participant
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Lower limb muscle power during a sit-to-stand test
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
The power (watt) needed to perform 5 sit-to-stand transitions and a 30 sec.
sit-to-stand test is calculated using a 3D accelerometer (DynaPort MoveTest, McRoberts), worn at the back of the participant
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Reliability of power measurements measured with a 3D accelerometer
Time Frame: 1 test moment of approximately 30 minutes, planned between September 2019 and July 2020
|
Reliability of power measurements (watt) measured with a 3D accelerometer (DynaPort MoveTest, McRoberts) worn during functional activities (stair climbing, sit-to-stand test) three times within a period of 2 weeks
|
1 test moment of approximately 30 minutes, planned between September 2019 and July 2020
|
|
Rate of power (force-velocity) development
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
Participants perform a test protocol on a Biodex Dynamometer.
The rate of power development (watt/s) is defined as the linear slope of the power-time curve and is measured from the onset of movement till peak power.
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Handgrip strength
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
Handgrip strength (kg) evaluated with a Jamar dynamometer
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Jumping height
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
Jumping height (in cm) measured during a standardized jump test
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Physical activity
Time Frame: 1 week
|
Objective measurement of physical activity in a subgroup of older participants (n=50) by means of accelerometry
|
1 week
|
|
Number of steps/stairs a day
Time Frame: 1 week
|
Objective measurement of physical activity in a subgroup of older participants (n=50) by means of accelerometry
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of repetitions during a 30s sit-to-stand test
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
Number of complete sit-to-stand transitions in 30 sec.
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
6min walk distance
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
The walk distance (in m) covered in 6 min.
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Balance
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
Number of seconds a participant can hold a tandem stand, a semi-tandem stand or with the feet together
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Maximal gait speed
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
The average speed to walk 3m as fast as possible (in m/s)
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Usual gait speed
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
The average speed to walk 4m at a usual pace (in m/s)
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Maximal isometric strength
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
Maximal strength (Nm) is measured by means of unilateral isometric knee-extensor tests on a Biodex Dynamometer
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
|
Maximal isokinetic strength
Time Frame: 1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
Maximal strength (Nm) is measured by means of unilateral isokinetic knee-extensor tests on a Biodex Dynamometer
|
1 test moment of approximately 1 hour, planned between September 2019 and July 2020
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- S62540
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Arizona State UniversityActive, not recruiting
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
Clinical Trials on Muscle function test
-
KU LeuvenCompleted
-
Mustafa Kemal UniversityUnknownParkinson Disease | Muscle Weakness | Surgery | Respiration; DecreasedTurkey
-
Hacettepe UniversityRecruitingCongenital Heart Disease | Fontan ProcedureTurkey
-
Biruni UniversityAtlas UniversityCompletedChronic Obstructive Pulmonary DiseaseTurkey
-
Bezmialem Vakif UniversityCompletedCystic Fibrosis | Primary Ciliary DyskinesiaTurkey
-
Atlas UniversityCompleted
-
Karolinska University HospitalCompleted
-
University of ChileAsociación Chilena de Nutrición Clínica, Obesidad y MetabolismoCompletedMuscle Function, Handgrip Strength TestChile
-
Rigshospitalet, DenmarkMerck Sharp & Dohme LLC; Roche Pharma AG; Beckett Foundation; Onkologisk ForskningsfondUnknownUrinary Bladder NeoplasmDenmark
-
Çağtay MadenCompletedForward Head Posture | Muscle Tone | Muscle Stiffnes | Muscle Elasticty | Vital CapacityTurkey